Infliximab Concentrations in Participants with Moderate to Severe COVID-19. Article uri icon

Overview

publication date

  • December 14, 2023

Research

keywords

  • Antirheumatic Agents
  • COVID-19

Identity

Scopus Document Identifier

  • 85179938686

Digital Object Identifier (DOI)

  • 10.1002/jcph.2388

PubMed ID

  • 38031826

Additional Document Info

volume

  • 64

issue

  • 4